APLS — Apellis Pharmaceuticals, Inc. | XLV Holdings | StockAdder

(APLS)

Apellis Pharmaceuticals, Inc.

Live chart and latest APLS stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

APLS News

Apellis Pharmaceuticals (APLS) hits 2-year high on 140% upside from Biogen merger

Apr 15, 2026 Stock Titan

Biogen (NASDAQ: APLS) bids $41 per share plus up to $4 CVR for Apellis

Apr 14, 2026 simplywall.st

Is It Time To Reconsider Apellis Pharmaceuticals (APLS) After Its Recent Share Price Slump?

Mar 27, 2026 Stocktwits

APLS Stock Soars 140% Today – Here’s Everything To Know About Apellis' Massive $5.6B Deal With Biogen

Mar 31, 2026 ChartMill

APLS Stock Alert: Halper Sadeh LLC is Investigating Whether Apellis Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

Mar 31, 2026 Barchart

Apellis Pharma Skyrockets on Biogen Deal. Is It Too Late to Chase APLS Stock?

Mar 31, 2026 Yahoo Finance

Cantor Fitzgerald Cuts PT on Apellis Pharmaceuticals (APLS) to $31 From $35 – Here’s Why

Mar 31, 2026 Stock Titan

Apellis (APLS) director shifts 5,750 trust shares to spouse account

Apr 8, 2026 Yahoo Finance

Here is Why JPMorgan is Overweight on Apellis Pharma (APLS)

Mar 10, 2026 Stock Titan

Biogen’s $5.6B Apellis deal adds 2 approved drugs and kidney push

Mar 31, 2026 Yahoo Finance

Apellis Pharmaceuticals (APLS) Moves 135.4% Higher: Will This Strength Last?

Apr 1, 2026 Stock Titan

Biogen (NASDAQ: APLS) files Form 3 on Apellis voting group status

Apr 6, 2026 Yahoo Finance

Apellis Pharmaceuticals (APLS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Feb 24, 2026 Stock Titan

[SCHEDULE 13D] Apellis Pharmaceuticals, Inc. Major Shareholder Acquisition (>5%)

Apr 6, 2026 Stock Titan

Are APLS, KORE, CNTA Obtaining Fair Deals for their Shareholders?